NO20001142L - Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister - Google Patents

Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister

Info

Publication number
NO20001142L
NO20001142L NO20001142A NO20001142A NO20001142L NO 20001142 L NO20001142 L NO 20001142L NO 20001142 A NO20001142 A NO 20001142A NO 20001142 A NO20001142 A NO 20001142A NO 20001142 L NO20001142 L NO 20001142L
Authority
NO
Norway
Prior art keywords
agonists
aromatic
substituted tetrahydro
prostaglandins useful
prostaglandins
Prior art date
Application number
NO20001142A
Other languages
English (en)
Other versions
NO20001142D0 (no
Inventor
John August Wos
Mitchell Anthony Delong
Jr Jack S Amburgey
Biswanath De
Haiyan George Dai
Cynthia Jean Miley
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20001142D0 publication Critical patent/NO20001142D0/no
Publication of NO20001142L publication Critical patent/NO20001142L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO20001142A 1997-09-09 2000-03-06 Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister NO20001142L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5824697P 1997-09-09 1997-09-09
PCT/US1998/018340 WO1999012896A1 (en) 1997-09-09 1998-09-04 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists

Publications (2)

Publication Number Publication Date
NO20001142D0 NO20001142D0 (no) 2000-03-06
NO20001142L true NO20001142L (no) 2000-05-04

Family

ID=22015602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001142A NO20001142L (no) 1997-09-09 2000-03-06 Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister

Country Status (23)

Country Link
US (1) US6107338A (no)
EP (1) EP1021402B1 (no)
JP (1) JP2001515883A (no)
KR (1) KR20010023837A (no)
CN (1) CN1269785A (no)
AR (1) AR017077A1 (no)
AT (1) ATE310721T1 (no)
AU (1) AU741014B2 (no)
BR (1) BR9811779A (no)
CA (1) CA2303763C (no)
CO (1) CO4970730A1 (no)
DE (1) DE69832513T2 (no)
ES (1) ES2253826T3 (no)
HU (1) HUP0004436A3 (no)
IL (1) IL134792A0 (no)
NO (1) NO20001142L (no)
NZ (1) NZ503736A (no)
PE (1) PE123199A1 (no)
PL (1) PL339213A1 (no)
SK (1) SK3362000A3 (no)
TR (1) TR200000670T2 (no)
WO (1) WO1999012896A1 (no)
ZA (1) ZA988231B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586468B1 (en) * 1998-09-14 2003-07-01 Ono Pharmaceutical Co., Ltd. ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
AU776375B2 (en) 1999-08-04 2004-09-09 Duke University Novel 2-decarboxy-2-phosphinico prostaglandin F analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6376533B1 (en) * 2000-10-20 2002-04-23 Allergan Sales, Inc. Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6586462B2 (en) 2000-10-20 2003-07-01 Allergan, Inc. ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
US7590997B2 (en) 2004-07-30 2009-09-15 Broadband Itv, Inc. System and method for managing, converting and displaying video content on a video-on-demand platform, including ads used for drill-down navigation and consumer-generated classified ads
US7631336B2 (en) 2004-07-30 2009-12-08 Broadband Itv, Inc. Method for converting, navigating and displaying video content uploaded from the internet to a digital TV video-on-demand platform
US20060135609A1 (en) * 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP2349242B1 (en) 2008-10-29 2018-12-05 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8394826B2 (en) 2009-05-01 2013-03-12 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
EP2768799B1 (en) 2011-10-17 2019-08-07 Biotheryx Inc. Substituted biaryl alkyl amides
EP3811943B1 (en) 2013-03-15 2023-02-22 Aerie Pharmaceuticals, Inc. Compound for use in the treatment of ocular disorders
CN104140410B (zh) * 2013-05-09 2017-12-15 江苏豪森药业集团有限公司 鲁比前列酮的制备方法
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
BR112019003945A2 (pt) 2016-08-31 2019-05-21 Aerie Pharmaceuticals, Inc. composições oftálmicas
CN110506037A (zh) 2017-03-31 2019-11-26 爱瑞制药公司 芳基环丙基-氨基-异喹啉酰胺化合物
WO2020056345A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011262A (en) * 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
IL50310A (en) * 1972-11-08 1977-08-31 Pfizer Dimethyl ketophosphonates
JPS5720305B2 (no) * 1973-02-28 1982-04-27
DE2365101A1 (de) * 1973-12-21 1975-07-10 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
DE2460990A1 (de) * 1974-12-21 1976-07-01 Hoechst Ag Neue prostaglandin-analoga und verfahren zu ihrer herstellung
DE2737808A1 (de) * 1976-08-27 1978-03-16 Pfizer 2-substituierte aryl-heterocyclische omega-pentanorprostaglandine
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
DE4024347A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6169111B1 (en) * 1995-06-07 2001-01-02 Alcon Laboratories, Inc. Conformationally rigid aryl prostaglandins for use in glaucoma therapy
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US5703108A (en) * 1996-02-28 1997-12-30 Pfizer Inc. Bone deposition by certain prostaglandin agonists
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
DE69714698T2 (de) * 1996-06-10 2002-12-05 Sucampo Ag, Zug Endothelin-antagonisten
DE69714274T3 (de) * 1996-09-17 2006-06-01 Asahi Glass Co., Ltd. Fluorierte prostaglandinderivate und medikamente
US6353014B1 (en) * 1996-11-12 2002-03-05 Alcon Laboratories, Inc. 15-ketal postaglandins for the treatment of glaucoma or ocular hypertension
AU5436198A (en) * 1996-11-12 1998-06-03 Alcon Laboratories, Inc. 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
CA2293325C (en) * 1997-05-09 2008-09-02 The Mount Sinai School Of Medicine Of The City University Of New York 8-iso-prostaglandins for glaucoma therapy

Also Published As

Publication number Publication date
BR9811779A (pt) 2000-09-12
IL134792A0 (en) 2001-04-30
WO1999012896A1 (en) 1999-03-18
US6107338A (en) 2000-08-22
JP2001515883A (ja) 2001-09-25
DE69832513T2 (de) 2006-07-13
PE123199A1 (es) 2000-02-02
CO4970730A1 (es) 2000-11-07
AU741014B2 (en) 2001-11-22
CA2303763A1 (en) 1999-03-18
CN1269785A (zh) 2000-10-11
EP1021402A1 (en) 2000-07-26
ZA988231B (en) 1999-03-09
DE69832513D1 (de) 2005-12-29
NO20001142D0 (no) 2000-03-06
SK3362000A3 (en) 2000-10-09
EP1021402B1 (en) 2005-11-23
PL339213A1 (en) 2000-12-04
KR20010023837A (ko) 2001-03-26
CA2303763C (en) 2007-04-24
HUP0004436A3 (en) 2001-09-28
ES2253826T3 (es) 2006-06-01
NZ503736A (en) 2002-06-28
TR200000670T2 (tr) 2000-11-21
HUP0004436A2 (hu) 2001-05-28
AR017077A1 (es) 2001-08-22
AU9219498A (en) 1999-03-29
ATE310721T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
NO20001141D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001142D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001139D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20010603D0 (no) 2-substituert-1-piperidylbenzimidazol forbindelser som ORL 1- reseptor agonister
NO20011738L (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DE69711519D1 (de) Carbazolanaloge als selektive beta3-adrenergische Agonisten
DK1019077T3 (da) Hidtil ukendte exendinagonistforbindelser
DK1930330T3 (da) Pleuromutilinderivater som antimikrobielle midler
EE200000044A (et) Uued ühendid
IS5430A (is) Ný samsetning
IS5522A (is) Ný bispidínsambönd við hjartsláttartruflunum
EE200000041A (et) Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO992470L (no) 2-amidazolinyl-amino-indolforbindelser anvendelige som <alfa>-2-adreno-reseptoragonister
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DE69834219D1 (de) Demultiplexer
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
DK0944601T3 (da) Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
NO20011038D0 (no) Substituerte dihydrobenzopyraner nyttige som antiarytmiske midler
DE69802830D1 (de) Aromatische substituierte naphtopyranen
FI974550A0 (fi) Styrsystem foer en soekmaskin, som anvaends i samband med ett data- eller telekommunikationsnaet
FI980722A0 (fi) Motions-, rehabiliterings-, sport- och lagspelredskap som staerker baolens muskler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application